Moderna Inc (LTS:0A45)
$ 39.3575 -1.0175 (-2.51%) Market Cap: 15.50 Bil Enterprise Value: 9.98 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 58/100

Moderna Inc at Nasdaq Virtual Investor Conference Transcript

Dec 04, 2020 / 05:00PM GMT
Release Date Price: $152.28 (+1.52%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Okay. I think we're live. So great. So thanks, everybody, for joining us for the next presentation. Very pleased to have Stéphane Bancel, who's the CEO of Moderna.

I just need to read a quick disclaimer statement. So for important disclosures, please see Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative. (Operator Instructions)

Questions & Answers

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

So Stéphane, thanks for joining. Nice to see you again. I thought we'd start with COVID, which is a big surprise to everybody.

Look, we've got data on 3 vaccines now, including yours. Maybe you could put your data into context, how you see your data versus the field, and we can go from there.

StÃ;phane Bancel
Moderna, Inc. - CEO & Director

© -

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot